Data / Form D filings / Gasami Therapeutics, Inc.
Gasami Therapeutics, Inc.: Form D filing
Gasami Therapeutics, Inc., a biotechnology company in Richmond, VA, filed a Form D with the SEC in 2026. The latest, on January 12, 2026, reports $20,000 sold of a $250,000 offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 8401 MAYLAND DR #5432, Richmond, VA, 23294
- Phone
- (434) 282-1615
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2025
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2104347
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 12, 2026 | New notice | $250,000 | $20,000 | $230,000 | 1 | Dec 4, 2025 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Sarah Hunter-Chang | Executive Officer |
Other biotechnology companies in Virginia that filed recently
- GENHEALTH, INC. $16.5 million · Sep 29, 2026
- SalivIQ Diagnostics Inc. $1.9 million · Sep 23, 2026
Every Form D from the week of Jan 12, 2026 · All recent filings in Virginia · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Gasami Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.